ReviewPharmacological reports : PR2023

Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapy.

Syed Sahajada Mahafujul Alam et al.PubMed ↗Publisher ↗

No numbers read from the abstract.